Omeprazole and Drooling - a phase IV clinical study of FDA data
Summary:
Drooling is found among people who take Omeprazole, especially for people who are female, 30-39 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Omeprazole and have Drooling. It is created by eHealthMe based on reports of 351,142 people who have side effects when taking Omeprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
351,142 people reported to have side effects when taking Omeprazole.
Among them, 328 people (0.09%) have Drooling.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 360,002 Omeprazole users for its effectiveness, alternative drugs and more.
What is Drooling?
Drooling (drop saliva uncontrollably from the mouth) is found to be associated with 1,424 drugs and 913 conditions by eHealthMe.
Number of Omeprazole and Drooling reports submitted per year:
Time on Omeprazole when people have Drooling *:
Gender of people who have Drooling when taking Omeprazole*:
Age of people who have Drooling when taking Omeprazole *:
Common drugs people take besides Omeprazole *:
Common side effects people have besides Drooling *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Drooling?
Check whether Drooling is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Drooling and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole:
- Drooling and drugs with ingredients of omeprazole (239 reports)
Alternative drugs to, pros and cons of Omeprazole:
- Omeprazole (360,002 reports)
Common Omeprazole side effects:
- Fatigue (feeling of tiredness): 22,124 reports
- Diarrhea: 20,344 reports
- Chronic kidney disease: 19,690 reports
- Breathing difficulty: 18,194 reports
- Pain: 15,867 reports
- Drug ineffective: 15,549 reports
- Weakness: 15,449 reports
Browse all side effects of Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zDrooling treatments and more:
- Drooling (7,134 reports)
COVID vaccines that are related to Drooling:
- Drooling in Moderna COVID Vaccine
- Drooling in Pfizer BioNTech Covid Vaccine
- Drooling in Johnson and Johnson Covid Vaccine
Common drugs associated with Drooling:
- Ingrezza: 768 reports
- Clonazepam: 358 reports
- Abilify: 347 reports
- Omeprazole: 328 reports
- Risperdal: 281 reports
- Loraz: 273 reports
- Lorazepam: 273 reports
- Diazepam: 255 reports
- Clozapine: 251 reports
- Aspirin: 236 reports
All the drugs that are associated with Drooling:
- Drooling (1,424 drugs)
Common conditions associated with Drooling:
- Tardive dyskinesia: 587 reports
- Depression: 377 reports
- Schizophrenia: 355 reports
- Parkinson's disease: 267 reports
- Bipolar disorder: 219 reports
- High blood pressure: 215 reports
All the conditions that are associated with Drooling:
- Drooling (913 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rogaine Extra Strength and Papilloedema - 12 seconds ago
- Mebeverine Hydrochloride and Celebrex drug interaction - 16 seconds ago
- Veletri and Blood Disorder - 24 seconds ago
- Parkinson'S Disease Aggravated and Excessive Or Unwanted Hair In Women - 31 seconds ago
- Pimavanserin and Protonix drug interaction - 40 seconds ago
- Imodium and Pathological Fracture - 44 seconds ago
- Lithium Carbonate and Flecainide Acetate drug interaction - a minute ago
- Epitol and Gastrointestinal Haemorrhage - a minute ago
- Benzonatate and Thyroiditis - a minute ago
- Hot Flush and drugs of ingredients of phosphatidylserine - a minute ago